StockMarketWire.com - Advanced Oncotherapy said it had commenced, along with medical centre Cleveland Clinic, a two-year study to evaluate radiotherapy treatments.

More specifically, the study would evaluate the target conformity of proton minibeams in comparison with X-ray stereotactic body radiation therapy and stereotactic radiosurgery.

'The use of a smaller beam means greater accuracy in targeting the desired tissue, which is essential when treating tumours near critical organs, particularly for the edge of the tumours,' the company said.


At 2:13pm: [LON:AVO] Advanced Oncotherapy PLC share price was 0p at 38p



Story provided by StockMarketWire.com